Prevalence and patterns of cognitive impairment in sporadic ALS

By G. Ringholz, S. Appel, M. Bradshaw, N. Cooke, D. Mosnik, Paul E. Schulz. Neurology, 2005

866 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Neurology

View Paper: https://www.semanticscholar.org/paper/634f5b6f432b5f76b052cfd1afb541a300bc2744

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. P. van Damme

Citations in the corpus

• EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force (2012, background): “Approximately 5–15% of patients with ALS meet the diagnostic criteria for frontotemporal dementia, typically frontal variant with executive dysfunction and behaviour change [168,169] (Class III) EFNS Task Force on Management of ALS 373”
• Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria (2017, background): “In a study of 279 ALS patients (78),52% met diagnostic criteria for AD, a frequency lower than the national rate of AD in 4% of the US population of adults below age 64 years (88).”
• Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis (2013, neutral): “It is estimated that 15% of FTD patients meet ALS criteria (Ringholz et al., 2005), and ALS can be accompanied by cognitive and behavioral impairment, with perhaps as much as 15% of affected individuals also developing symptoms consistent with a typical definition of FTD (Ringholz et al., 2005;…”